| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.45 | 2e-25 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.23 | 3e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.068 | 0.2 |